Introduction
The June BC TALKS will feature five expert physicians: Prof. Michael Gnant (Austria), Prof. Marc Thill (Germany), Prof. Maria-João Cardoso (Portugal) and Prof. Giancarlo Pruneri (Italy).
This will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A
Objectives
• Share data on the latest data for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice. It will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A
This Course For :
Physician
( Oncology )
Resident / Fellow
( Oncology )
Speaker
Prof. Giancarlo Pruneri MD | Italy
Head, Dpt. of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan; Full Professor of Pathology, University of Milan, School of Medicine; President, Euro-Asian Mastology Association.
Dr. Marc Thill MD, PhD | Germany
Chief physician of the Clinic for Gynecology and Gynecologic Oncology of the Agaplesion Markus Hospital in Frankfurt, Germany. He has authored numerous publications.
Prof. Maria-João Cardoso MD, PhD | Portugal
Head Breast Surgeon, Champalimaud Foundation Breast Unit, Lisbon Portugal. Associate Professor, University of Lisbon Faculty of Medicine.
Prof. Michael Gnant MD | Austria
Full Professor of Surgery and President of the Austrian Breast & Colorectal Cancer Study Group at the Medical University of Vienna, Austria. Author of more than 500 original peer-reviewed papers.
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
11 Jun 2024 To 11 Jun 2024 -
07:00 PM To 08:00 PM 
Certificate Available 
Online Click Here
- 34
Add to Calendar
06/11/2024 07:00 PM
06/11/2024 08:00 PM
Asia/ Riyadh
Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification
Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification
https://medicalacademy.org/portal/event/view/2177
